TABLE 4

Experimental details by company (Vesicles)

Lab IDVesicle SourceFiltration Method (Vac. Manifold, Cell Harvester, etc.)Protein/WellAssay TemperatureFilter Plate Vendor Plus Cat. No.Signal-to-Noise Acceptance CriteriaSubstrate and Conc.Assay Buffer and Solvent ContentPre- incubationa/Assay TimePlate ShakingPositive Control Inhibitor
mgμMminrpmconc.
23In-houseVacuum manifold (Millipore)5037°CMillipore, MSFBN6B50, MultiScreen HTS96-well, GF/B, 1.0 μm>6-Fold difference between ATP+ and ATP–3H-NMQa 1250 mM sucrose, 10 mM TrisHCl, 10 mM MgCl25/2YesN/A
pH 7.0, +/− 4 mM ATP, 1% DMSO
26In-house and Solvo96-Channel cell harvester (PerkinElmer)20 Lilly37°CPerkinElmer; 600517796-well GF/B, 1.0 μmAMP-PNP value = inhibitor control3H Vinblastine 0.1250 mM sucrose, 10 mM TrisHCl, 10 mM MgCl210/2.5YesLSN335984, (5µM)
40 SolvopH 7.4 with 4 mM ATP, ATP with 5 µM LSN335984, or 4 mM AMP-PNP, 0.5% DMSO
22SolvoVacuum manifold (Millipore)5037°CMillipore, MSFBN6B10, MultiScreen 96-well, GF/B, 1.0 μm>3-Fold difference between ATP+ and ATP-NMQ 2250 mM sucrose, 10 mM TrisHCl, 10 mM MgCl215/3NoKetoconazole 8 pt IC50
pH 7.0, +/− 4 mM ATP, 1% DMSO
21SolvoVacuum manifold (Millipore)5037°CMillipore, MSFBN6B50, MultiScreen HTS 96-well, GF/B, 1.0 μm>3-Fold difference between ATP+ and ATP-3H-NMQ 1Assay buffer (and all other buffers) from PREDIVEZ Vesicular Transport Kit (SOLVO)15/2YesVinblastine or erythromycin 4 pt IC50
+/− 4 mM ATP, 1% DMSO
20SolvoVacuum manifold (Millipore)5037°CMillipore, MSFBN6B50, MultiScreen HTS 96-well, GF/B, 1.0 μm>6-Fold difference between ATP+ and ATP–3H-NMQ 2250 mM sucrose, 10 mM TrisHCl, 10 mM MgCl2pH 7.0, +/− 4 mM ATP, 1% DMSO15/3NoN/A
  • For abbreviations, see Table 1.

  • a NMQ, N-methylquinidine.